Elevance Health, Inc. (elv)
ELV Estimates
Public analyst price targets and consensus snapshot for Elevance Health, Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $398.56 |
| Analyst mean target | $451.38 |
| Analyst high target | $492.00 |
| Analyst low target | $393.00 |
| Upside vs mean target | 13.3% |
| Consensus recommendation | Strong Buy |
| Number of analysts | 21 |
| Forward P/E | 13.49 |
Start Free — open ELV in Vest Terminal
Access live data, filings, ownership, and analysis for Elevance Health, Inc..
Elevance Health, Inc. FAQ
What does Elevance Health, Inc. (ELV) do?
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to indi…
What is ELV's P/E ratio?
Elevance Health, Inc. has a trailing P/E of 17.79× based on publicly available market data.
Does ELV pay a dividend?
Indicated dividend yield: 1.7%. Confirm ex-dates and payout history in Vest Terminal.
What sector is ELV in?
Elevance Health, Inc. is classified in Healthcare (Healthcare Plans) on NYQ.
What is ELV's market capitalization?
Approximate market cap: $86.44B.
What are the main risks for ELV?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of ELV?
Potential positives include positive free cash flow ($4.31b), dividend yield of 1.7% for income-oriented holders.
Where can I get analyst estimates for ELV?
Public analyst price targets and consensus for Elevance Health, Inc. are on the free /stocks/elv/estimates page. Deeper estimate history and models are available in Vest Terminal.